Artemin (ARTN) is a member of the glial cell linederived neurotrophic factor (GDNF) family ligands (GFLs) which regulate the development and maintenance of many neuronal populations in the mammalian nervous system. Here we report the 1.92 Å crystal structure of the complex formed between ARTN and its receptor GFRa3, which is the initiating step in the formation of a ternary signaling complex containing the shared RET receptor. It represents a new receptorligand interaction mode for the TGF-b superfamily that reveals both conserved and specificity-determining anchor points for all GFL2GFRa pairs. In tandem with the complex structure, cellular studies using receptor chimeras implicate dyad-symmetric composite interfaces for recruitment and dimerization of RET, leading to intracellular signaling. These studies should facilitate the functional dissection of the specific versus pleiotropic roles of this system in neurobiology, as well as its exploitation for therapeutic applications.
Introduction
The glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) include GDNF (Lin et al., 1993) , neurturin (NRTN) (Kotzbauer et al., 1996) , persephin (PSPN) , and artemin (ARTN) . GFLs play critical roles in supporting the development and survival of distinct sets of central and peripheral neurons (Airaksinen and Saarma, 2002; Baloh et al., 2000a) . The potent neurotrophic activities of GFLs have stimulated interest in their use as therapeutic agents for the treatment of neurodegenerative diseases such as Parkinson's. GDNF, the founding member in the family, has shown antiparkinsonian actions in various animal models and pilot studies with human patients (Gill et al., 2003; Grondin and Gash, 1998; Slevin et al., 2005) . ARTN has been shown in recent studies to be effective as a systemic treatment for neuropathic pain (Gardell et al., 2003) . Given the importance of GFLs in basic neurobiology and their potential therapeutic value, it has become a compelling goal to understand the molecular basis of the interactions between GFLs and their receptors.
GFLs belong to the transforming growth factor b (TGF-b) family because of the conserved seven cysteine residues and structural similarities, but they are different from other members in the signaling pathway (Saarma, 2000) . Unlike other members in the TGF-b family (TGF-bs, BMPs, Activins, etc.) which signal through direct engagement of two different types of serine/ threonine receptor kinases (Massague and Chen, 2000) , GFLs exert their activities through the nucleation of a ternary complex containing a nonsignaling, ligandspecific GFRa receptor and a signaling and shared tyrosine kinase receptor RET (Durbec et al., 1996; Treanor et al., 1996; Trupp et al., 1996; Worby et al., 1996) . One widely accepted model is that GFL first binds its preferential GFRa receptor. This binary complex, then, recruits RET through the formation of a composite GFL/GFRa interface, which triggers the activation of the intracellular tyrosine kinase domain (Airaksinen et al., 1999) . The GFRa receptors contain three cysteine-rich repeats that appear to mark distinct extracellular domains (D1, D2, and D3). Four different GFRa receptors (GFRa1-4) have been identified Buj-Bello et al., 1997; Enokido et al., 1998; Jing et al., 1996) , and it is now established that GFRa1 binds preferentially to GDNF, GFRa2 to NRTN, GFRa3 to ARTN, and GFRa4 to PSPN (Airaksinen et al., 1999) .
The protein fold of GDNF is a canonical ''cystine-knot'' motif, formed by a hallmark pattern of seven cysteine residues within the primary sequence, and one interchain disulfide bond linking two GDNF monomers to form a homodimer (Eigenbrot and Gerber, 1997; Sun and Davies, 1995) . The structure of a single unliganded domain corresponding to the third cysteine-rich repeat (D3) of GFRa1 has been reported, which did not posses ligand binding activity, but from which the GDNF interactions were modeled (Leppanen et al., 2004) . In order to begin to elucidate the molecular basis of GFL receptor recognition and activation, we report here the crystal structure of ARTN bound to the ligand binding domains of GFRa3, together with cellular studies that collectively point to a convergent binding and activation mode between GFL and their receptors across this important neurotrophic factor family.
Results

Biochemical Studies and Structure Determination
A soluble ectodomain of human GFRa3 (D1D2D3) (residues 32-363) with a C-terminal hexa-histidine tag, and human ARTN (residues 139-237) without His-tag were coexpressed in insect cells. Gel filtration chromatography of the Nickel-agarose captured material resolved a major peak consisting of the ARTN2GFRa3 complex, followed by excess GFRa3 ( Figure 1A ). The molecular weight of the ARTN2GFRa3 complex determined by *Correspondence: kcgarcia@stanford.edu multiangle laser light scattering (MALS) is 98.5 kDa ( Figure 1B) , indicating the complex consists of two receptor molecules and one ARTN homodimer. The 1:2 stoichiometry was further validated by isothermal titration calorimetry ( Figure 1C ), which indicated that the complex is composed of one ARTN homodimer and two GFRa3 (D1D2D3) receptors.
During crystallization, the GFRa3 N-terminal domain (D1) was spontaneously proteolyzed by remaining trace quantities of proteases after purification. This digestion resulted in the formation of crystals containing a complex consisting of the GFRa3 D2D3 domains (residues 146-363) and one ARTN homodimer, which was confirmed by N-terminal sequencing of washed crystals.
That D1 is dispensable for ARTN2GFRa3 complex formation is consistent with previous findings that GFRa4 as well as some isoforms of GFRa2 do not contain a D1, indicating it is not required for GFL binding or recruitment of RET (Airaksinen et al., 1999; Scott and Ibanez, 2001) . A combination of heavy atom phasing and molecular replacement methods were used to determine the complex structure at 1.92 Å resolution, as well as two different unbound ARTN structures at resolutions of 1.76 Å and 2.6 Å , respectively ( Figure 1D and Table 1 ).
Overall Structure of the ARTN-GFRa3 Complex
The complex consists of a single ARTN homodimer together with two GFRa3 D2D3 molecules in a 1:2 (Figures 2A and 2B ). One symmetric ARTN dimer binds two GFRa3 molecules at each of its two distal tips, resulting in the complex spanning w130 Å in the dimension parallel to the cell membrane ( Figure 2A ). The noncrystallographic 2-fold related halves of the complex are highly similar to each other ( Figure 2B ), being related by a rotation of w179º and with a root-mean-square difference (rmsd) of w0.6 Å for 298 Ca positions.
ARTN Homodimer
ARTN is a homodimer in which the two monomers are assembled in a ''tail-to-head'' fashion, linked by an interchain disulfide bond (Figures 2A and 2B ). The ARTN monomer structure is composed of two b sheet fingers, a cystine-knot core motif, and an a-helical heel region. The finger 1 is composed of two long continuous antiparallel b strands, and finger 2 has interruptions in the middle, resulting in five relatively short b strands in the b sheet. In the dimer, the helix in the heel region of one ARTN monomer contacts the finger region of another monomer with its helical axis nearly perpendicular to the b strands (Figures 2A and 2B ). The structure of ARTN bound to GFRa3 is very similar to the two unbound structures, as reflected in the rmsd of w1 Å for Ca superimposition in both monomer and dimer levels. Structural comparison of ARTN with GDNF shows an approximate 20º difference in the angle between the finger and heel regions, which results in poor monomer superimposition (w7 Å rmsd) and different homodimer orientations (Figures S1B and S1C; see the Supplemental Data available with this article online).
GFRa3 ''D2D3'' Module
The compact globular structure of the GFRa3 D2D3 fragment was unexpected based on speculation that the GFRa fold into three independent domains (Leppanen et al., 2004) . Instead, the ''D2D3'' modules are closely packed together, with each cysteine-rich repeat domain contributing five a helices (a1-a5 for D2, a6-a10 for D3) that then stack in two roughly triangular spirals ( Figure 2C ). The interface between the two domains forms a large hydrophobic core between the outermost helices (a3 and a4) of the D2 domain with the innermost helices (a8, a10 and a8-a9 linker) of the D3 domain, respectively. The residues involved in the hydrophobic interactions include Leu200, Phe204, Leu216, Leu217, Leu289, Tyr292, Leu293, Ile296, Phe304, and Ile345, which are highly conserved in all GFRa receptors. The disulfide-bond pattern is very similar in both D2 and D3, which has five disulfide bonds distributed at the three corners of the triangular spiral to fix the scaffold ( Figure 2C ). There are no disulfide bonds in the interface between D2 and D3. Considering that all cysteine residues in the disulfide-bonds are conserved across the GFRa family and the correspondence of GFRa3 D3 to the isolated GFRa1 D3 domain previously solved (rmsd of w0.6 Å for 62 Ca atoms in the helical region) (Leppanen et al., 2004) (Figure S1A ; see the Supplemental Data available with this article online), we believe that other GFRa receptors will have similar architectures.
Overview of the ARTN/GFRa3 Binding Interface
The interaction of ARTN with GFRa3 occurs through the protruding tips of fingers 1 and 2 in ARTN inserting into a pocket in the center of a triangle of a helices in the D2 domain of GFRa3 ( Figure 3A ). The D3 domain has no interaction with ARTN. The role of the D3 domain appears to be to stabilize the D2 domain, in contrast to speculation that it forms direct ligand contacts (Leppanen et al., 2004) . As a result of complex formation, 16 residues from ARTN and 19 residues from GFRa3 bury a total of w1500 Å 2 surface (Figures 3C and 3D ; also see Table S1 in the Supplemental Data available with this article online). The interface between ARTN and GFRa3 can be described as a small hydrophobic core surrounded by a much larger halo of charged and hydrophilic interactions ( Figures 3C and 3D) , consistent with our thermodynamic measurements indicating that binding is enthalpy driven, which is usually a signature for polar and charged interactions ( Figure 1C ) (Carneiro , 2002; He et al., 2001) . Both apolar and polar segments in ARTN/GFRa3 contact interface contain conserved residues in GFLs and GFRa receptors. These conserved residues clearly serve as the common anchor points in all GFL2GFRa pairs, which are then surrounded by specificity determinants unique to each GFL2GFRa pair.
Conserved Hydrophobic and Hydrophilic Interactions
The protruding hydrophobic core at the ARTN fingertips, composed of Trp205 and Met199 ( Figure 3B ), is highly conserved in other GFLs ( Figures 4A and 4B ). It is structurally and chemically matched on the complementary GFRa3 surface formed by a recessed ring of exposing residues including Arg179, Tyr182, Gly183, Arg230, and Ala236 ( Figure 4B ). The main contact hydrophobic residue Tyr182 in GFRa3 is strictly conserved, and hydrophobic positions Gly183 and Ala236 are also replaced by hydrophobic residues in other GFRa receptors ( Figure 4C ). Upon complex formation, Trp205 and Met199 from ARTN undergo large sidechain movements and bury w28% of the total surface area in the interface ( Figure 3C ; also see Figure S1D in the Supplemental Data available with this article online). Underscoring the importance of Trp205 and Met199 positions, their mutations in GDNF result in a complete loss of binding activity for GFRa1 (Eketjall et al., 1999) .
The majority of the ARTN/GFRa3 interface is formed by several patches of matching complementary charge ( Figures 3C and 3D) . The conserved hydrophilic patch involves salt bridges between residue Glu143 from ARTN and residues Arg179 and Arg230 in GFRa3 ( Figure 3B ), which are strictly conserved in all GFRa receptors ( Figure 4C ). Glu143 is also strictly conserved in all GFLs ( Figure 4A ) and is one of the most important binding determinants for the interactions between GDNF and GFRa1 (Eketjall et al., 1999) . We therefore speculate that these two binding epitopes, one hydrophobic and one charged, constitute ''anchor'' points for GFLs interactions with their GFRa receptors.
GFL-GFRa Specificity Determinants
We also find three epitopes in the ARTN-GFRa3 complex that are potential determinants of specificity between GFLs and their preferential GFRa receptors. The first is a van der Waals interaction between positions Ala195 (ARTN) and Glu184 (GFRa3) ( Figure 3B ). The other three GFLs, GDNF, NRTN, and PSPN, have negatively charged residues (Asp or Glu) at position 195 ( Figure 4A ), and we expect that the repulsion from Asp-Glu or Glu-Glu would not favor the binding of GDNF, NRTN, and PSPN with GFRa3. Their preferential receptors GFRa1, GFRa2, and GFRa4 have small neutral residues at position 184 instead of a negatively charged residue ( Figure 4C ). A patch of complementary charge between Arg146 of ARTN and Asp176 of GFRa3 is another potential specificity determinant ( Figure 3B ). Receptors GFRa1 and GFRa2 both have Lys instead of Asp at position 176 ( Figure 4C ), which would result in repulsion by an Arg-Lys interaction in a mismatched ligand-receptor pair. The last potential determinant is a hydrophobic contact between Leu144 of ARTN and Met167 in GFRa3 ( Figure 3B ). The corresponding residues found at position 144 in GDNF, NRTN, and PSPN are Glu, Thr, and Lys, respectively, that match with Lys, Lys, and Glu, respectively, at position 167 in GFRa1, GFRa2, and GFRa4 ( Figures 4A and 4C ). These charge reversals would then be repulsive in mismatched complexes (GDNF-GFRa4, PSPN-GFRa1, and PSPNGFRa2).
To probe the importance of the D2D3 region of GFRa3 for interaction with artemin as well as RET, we generated mutant chimeric receptors between GFRa2 and GFRa3 and directly test their ability to form functional ternary receptor signaling complexes in response to NRTN and ARTN, respectively ( Figure 5 ). The experiment was done by transiently transfecting the chimeric receptor together with Gal4-Elk1/Gal4-luciferase reporter system into fibroblasts that stably express RET. This system, Substitution of GFRa3 D2 domain with that of GFRa2 results in conversion to NRTN specificity, while substitution of GFRa2 D2 domain with that of GFRa3 results in conversion to ARTN specificity. NIH-3T3 fibroblasts stably expressing human RET were transfected with the indicated construct, together with the Gal4-Elk1 fusion and a Gal4-luciferase reporter. Cells were deprived of serum, and stimulated with 50 ng/mL of the indicated ligand for 6 hr. Experiments were done in triplicate, and normalized to the response to the preferred ligand (ARTN for GFRa3, and NRTN for GFRa2). The residues in bold below correspond to the region conferring ligand specificity.
which utilizes the ability of the Gal4-Elk1 fusion protein to respond to MAP kinase activity and activate transcription of the Gal4-luciferase reporter, has been used previously to monitor NGF-TrkA activation of MAP kinase in PC12 cells and GDNF-RET activation of MAP kinase in neuroblastoma cell lines (Worby et al., 1996; York et al., 1998) . As expected, wild-type GFRa2 responded only to NRTN, and GFRa3 only to ARTN. A chimeric GFRa containing N-terminal GFRa2 (Ser22 to His160) together with C-terminal GFRa3 (Cys162 to Asn374) responded only to ARTN. In contrast, a chimera containing N-terminal GFRa2 (Ser22 to Ser213) with C-terminal GFRa3 (Pro210 to Asn374) responded only to NRTN, indicating that residues involved in ligand specificity lie between Cys162 and Glu209, in the D2 region of GFRa3. Confirming this, an additional chimera with N-terminal GFRa3 (Gly31 to Pro157) fused with C-terminal GFRa2 (Glu214 to Gln374), in which the D2 region was derived from GFRa2, maintained responsiveness only to NRTN. Therefore, these functional receptor studies indicate that the ligand specificity is dictated by the stretch of residues from Cys162 to Glu209, which is the major region of GFRa3 contacting ARTN in our structure.
Discussion
The activated receptor complexes of GFLs consist of the shared signaling tyrosine kinase receptor RET and ligand-specific nonsignaling GFRa coreceptors (Airaksinen and Saarma, 2002) . This receptor composition is unique in the TGF-b superfamily, because other members, such as BMPs, Activins, and TGF-bs, have two different types of serine/theronine receptor kinases (Massague and Chen, 2000) . Previous studies have revealed the complex structures of BMPs, Activins, and TGF-bs with their receptors, which all have one single b sheet fold in the receptor ectodomain ( Figures 6B-6E ) (Allendorph et al., 2006; Greenwald et al., 2003; Greenwald et al., 2004; Hart et al., 2002; Kirsch et al., 2000; Thompson et al., 2003) . Our ARTN2GFRa3 complex structure adds a new ligand-receptor binding mode in the TGF-b superfamily because the GFRa3 ectodomain has multiple domains mainly composed of a helices. Although still substantially different, the overall docking mode of ARTN with GFRa3 is most similar to that seen in the TGF-b32TbRII complex (Figures 6A and 6B) (Hart et al., 2002) , which also uses the ligand fingertips to engage receptor. Structural comparison of the ligand-receptor complexes in the TGF-b superfamily also shows different intermonomer angles in the homodimeric ligands (Figures 6A-6E ). Such homodimeric structural flexibility has been proposed to be a potential mechanism of receptor signaling modulation (Greenwald et al., 2004; Thompson et al., 2003) . Variable homodimer orientations have also been observed between ARTN and GDNF ( Figure S1C ; see the Supplemental Data available with this article online), and we propose that it would result in different relative orientations of two RET molecules in the ternary signaling complex, potentially influencing the activation of its intracellular kinase domains.
GFL must engage GFRa in order to recruit the shared tyrosine kinase receptor RET (Airaksinen and Saarma, 2002) , suggesting that RET recognizes a composite surface formed by the conjunction of GFL and GFRa receptor (Scott and Ibanez, 2001; Trupp et al., 1998) . Alternatively, ligand capture by GFRa on the membrane may increase the effective concentration of GFL at the cell surface for presentation to RET through a noncomposite RET binding surface on GFL, or the GFL binding will induce the conformational changes of the noncomposite RET binding surface on GFRa. The RET binding region of GFRa1 has been delimited to a region analogous to the GFRa3 ''D2D3'' module described here (Scott and Ibanez, 2001) . Given the shared usage of RET by all GFL2GFRa complexes, the RET binding surface on GFRa may be conserved. We found 12 conserved GFRa residues that map onto an exposed face, involving both D2 and D3, on one side of GFRa3 in the complex, thereby defining a potential RET binding site (Figure 7) . Most of these conserved residues are charged, which is consistent with homolog-scanning mutagenesis of RET, indicating that charged residues in the first cadherin-like domain of RET are important for formation of GDNF2GFRa12RET complex (Kjaer and Ibanez, 2003) . We propose that this face of GFRa3 forms part of the RET binding surface and includes residues from helices a2, a3, a7, a8, a9, and a10. This RET binding surface would be located adjacent to the two bottom fingers in ARTN (magenta highlighted in Figure 7 ), which could form part of the composite RET interaction surface. These ARTN residues do not interact with GFRa3; however, they are located within a region previously shown using GFL homolog scanning mutagenesis to be essential for RET activation (Baloh et al., 2000b) . Although there are several conserved residues on the opposite face of GFRa3, it is less likely to serve as the RET binding surface due to the presence of a bulky Asparagine (309)-linked glycan prominently in the middle of the region of possible interaction (Figure 7) . The two potential RET binding surfaces we proposed here are related by the intrinsic 2-fold symmetry and also angled toward one another in roughly a V-shape, such that two RET molecules, if bound along the approximate long axis of the GFRa, would be steered into closer apposition as it enters the cell membrane, resulting in reduced proximity of their intracellular kinase domains.
Experimental Procedures Protein Preparation
Proteins used in this study were expressed using the Baculovirus system (Pharmingen) in insect cells. Briefly, insect Spodoptera frugiperda (Sf9) cells were used for generating high titer recombinant virus and were cultured at 28ºC using SF900 II SFM medium (Invitrogen). Trichopulsia ni (High-Five) cells (Invitrogen) were used to express the recombinant protein and were grown in Insect Xpress medium (Cambrex) at 28ºC. Human GFRa3 ectodomain (residues Asp322Pro363) with C-terminal hexa-histidine and the N-terminal truncated human ARTN (Gly1392Gly237) . All data were collected at Advanced Light Source (UC Berkeley) and Stanford Synchrotron Radiation Laboratory. The data sets were collected at 100 K and processed using HKL2000 software suite (Otwinowski and Minor, 1997) . More statistics of crystal and data collection are in Table 1 .
Structure Determination and Refinement
The structure of unbound ARTN was first determined by single isomorphous replacement with anomalous scattering (SIRAS) method with a mercury derivative in P6 5 form, which has three dimers in the asymmetric unit. The derivative was prepared by soaking a single crystal in the mother liquor containing 100 mM Thimerosal for 1 hr. The heavy atom binding sites were determined with SHELXD (Schneider and Sheldrick, 2002) . The initial phases were calculated in SHARP (de la Fortrelle and Bricogne, 1997) and improved with SOLOMON (Abrahams and Leslie, 1996) . The ARTN model from P6 5 form was used to determine its structure in P6 5 22 form (one monomer per asymmetric unit) with PHASER (Read, 2001) . The structure of the ARTN2GFRa3 complex was determined by the molecular replacement method with our ARTN and GFRa1 D3 domain structures (PDB ID: 1Q8D) as the search models. Program PHASER (Read, 2001 ) was used to locate the positions of one ARTN dimer and two GFRa3 D3 domains in the complex. After density improvement with ARP/wARP (Perrakis et al., 1999) , the residues in the D2 domain were built into the map by using COOT (Emsley and Cowtan, 2004) . All structures were refined with CNS (Brunger et al., 1998) and REFMAC (CCP4 package) (Murshudov et al., 1997) . Structure determination and refinement statistics are listed in Table 1 .
Isothermal Titration Calorimetry (ITC) and Multiangle Light Scattering (MALS)
Calorimetry titrations were carried out on the VP-ITC calorimeter (MicroCal) at 20ºC, with 15 mM GFRa3 titrated against 2.5 mM ARTN dimer. Both GFRa3 and ARTN were prepared in a buffer containing 0.01 M Hepes (pH 7.2) and 0.5 M NaCl. The data were processed with the MicroCal Origin 7.0 software. A DAWN EOS (Waytt Technology) equipped with a K5 flow cell and a 30 mW linearly polarized GaAs laser of wavelength 690 nm was used in MALS experiment. Data analysis was carried out real time using ASTRA (Wyatt The 2-fold related potential RET binding sites are circled in dotted lines. Colored and labeled residues are conserved in GFRa receptors and surface-exposed in the GFRa3 structure. The magenta patch in ARTN are the corresponding regions found in GDNF to be important for RET activation.
Technologies) and molecular weight was calculated using the Debye fit method.
Receptor Activation Assays They were performed as described previously (Baloh et al., 2000b) . Briefly, 3T3 fibroblasts stably expressing human RET were plated at 85,000 cells/well in 12-well plates and transfected using Superfect (Qiagen) with the reporter plasmids (250 ng/well Gal4-Luc, 50 ng/ well Gal4-Elk), CMV-lacZ (50 ng/well) for transfection normalization, a CMV-GFRa (500 ng/well) expression plasmid, and 650 ng/well pBluescript as a carrier for a total of 1.5 mg of DNA/well. Cells were switched to 0.5% serum-containing medium the morning after transfection, stimulated for 6 hr with 50 ng ml 21 of recombinant artemin or neurturin, and harvested 36 hr after transfection. The average luciferase activity of triplicate samples was normalized to b-galactosidase activity of the cotransfected lacZ reporter to control for transfection efficiency.
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